Selected article for: "egfp expression and gene expression"

Author: Zhao, Ping; Qin, Zhao-Ling; Ke, Jin-Shan; Lu, Yang; Liu, Min; Pan, Wei; Zhao, Lan-Juan; Cao, Jie; Qi, Zhong-Tian
Title: Small interfering RNA inhibits SARS-CoV nucleocapsid gene expression in cultured cells and mouse muscles
  • Cord-id: 9966p02q
  • Document date: 2005_4_25
  • ID: 9966p02q
    Snippet: SARS-CoV is a newly identified coronavirus that causes severe acute respiratory syndrome (SARS). Currently, there is no effective method available for prophylaxis and treatment of SARS-CoV infections. In the present study, the influence of small interfering RNA (siRNA) on SARS-CoV nucleocapsid (N) protein expression was detected in cultured cells and mouse muscles. Four siRNA expression cassettes driven by mouse U6 promoter targeting SARS-CoV N gene were prepared, and their inhibitory effects on
    Document: SARS-CoV is a newly identified coronavirus that causes severe acute respiratory syndrome (SARS). Currently, there is no effective method available for prophylaxis and treatment of SARS-CoV infections. In the present study, the influence of small interfering RNA (siRNA) on SARS-CoV nucleocapsid (N) protein expression was detected in cultured cells and mouse muscles. Four siRNA expression cassettes driven by mouse U6 promoter targeting SARS-CoV N gene were prepared, and their inhibitory effects on expression of N and enhanced green fluorescence protein (EGFP) fusion protein were observed. A candidate siRNA was proved to down-regulate N and EGFP expression actively in a sequence-specific manner. The expression vector of this siRNA was constructed and confirmed to reduce N and EGFP expression efficiently in both cultured cells and adult mouse muscles. Our findings suggest that the siRNA should provide the basis for prophylaxis and therapy of SARS-CoV infection in human.

    Search related documents:
    Co phrase search for related documents
    • acute respiratory syndrome and lysis buffer: 1, 2, 3